Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
talented PhD students to develop and benchmark cutting-edge super-resolution imaging technologies. The project aims to establish a comprehensive approach for ultra-high-content, multimodal imaging
-
to neurodegenerative diseases of the central and peripheral nervous system, with an emphasis on understanding the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range
-
-regulatory network analysis approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis
-
. You will work on the cutting edge of both wind energy and machine learning, two of the fastest growing scientific disciplines, to develop machine learning surrogates of wind energy systems. As newer
-
, biochemistry, genomics, bacterial genetics and bioinformatics. You can work both independently as well as in an international team You can plan and perform laboratory experiments accurately You have strong
-
campuses, benefits, strategic goals and your future colleagues. Would you like more information about EUTOPIA? Go to eutopia-university.eu , and read more about the role of the VUB in the development
-
. It is one of the largest, most exciting employers in the area and offers great career opportunities. With its 11 faculties and more than 85 departments offering state-of-the-art study programmes
-
Learning Agreement is completely filled in and signed, dated and stamped where necessary! Language skills Your knowledge of Dutch and English. Please consult the language requirements in order to prepare the
-
offering state-of-the-art study programmes grounded in research in a wide range of academic fields, Ghent University is a logical choice for its staff and students. For the research unit “Physical activity
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment